A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial
National Cancer Institute (NCI)
Sumanta K Pal; Catherine Tangen; Ian M Thompson; Naomi Balzer-Haas; Daniel J George; Daniel Y C Heng; Brian Shuch; Mark Stein; Maria Tretiakova; Peter Humphrey; Adebowale Adeniran; Vivek Narayan; Georg A Bjarnason; Ulka Vaishampayan; Ajjai Alva; Tian Zhang; Scott Cole; Melissa Plets; John Wright; Primo N Lara
SWOG Statistics and Data Management Center, Seattle, WA, USA; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.